Skip to content

Clinical trials

Phase 3 Fallopian Tube Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Fallopian Tube Neoplasms Phase: Phase 3 Country / region: South Korea Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20071
20092
20102
20121
20151
20162
20171
20184
20193
20201
20211
20222
20231
20252
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting10
Completed6
Recruiting4
Unknown status4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)4
Merck Sharp & Dohme LLC3
AbbVie2
Amgen2
AstraZeneca2
Seoul National University Hospital2
Advenchen Laboratories, LLC1
CanariaBio Inc.1
Corcept Therapeutics1
Eli Lilly and Company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Fallopian Tube Neoplasms27
Ovarian Neoplasms22
Carcinoma, Ovarian Epithelial7
Peritoneal Neoplasms5
Brenner Tumor3
Neoplasms2
Adenocarcinoma, Clear Cell1
Adenocarcinoma, Mucinous1
Carcinoma1
Carcinosarcoma1

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.